Found 33 matching trials
Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France N/A Bronchiolitis is a viral lower respiratory tract infection, caused in 50 to...
Show More Location
Public health department, Hôpital Pitié Salpêtrière
Learn More & Join Trial
Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination. PHASE3 RSV (which stands for Respiratory Syncytial Virus) is an infection that cau...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults PHASE1 The purpose of this study is to evaluate the Pharmacokinetics, Safety, Tole...
Show More Learn More & Join Trial
THRIVE - Trial of Passive Humoral RSV Immunity for Value and Effectiveness PHASE4 RSV is a leading cause of severe respiratory illness and hospitalisation fo...
Show More Location
Menzies School of Health Research
Learn More & Join Trial
Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India PHASE4 The purpose of this study is to describe the safety and efficacy outcomes a...
Show More Status
Active Not Recruiting
Location
Investigational Site Number : 3560002
Learn More & Join Trial
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months PHASE1 The purpose of this study is to assess the safety and immunogenicity of mRN...
Show More Status
Active Not Recruiting
Location
Matrix Clinical Research
Learn More & Join Trial
Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization N/A A longitudinal observational study based on routinely collected data on hos...
Show More Location
Hospital Clínico Universitario de Santiago de Compostela
Learn More & Join Trial
BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study) N/A The primary objectives of the study are: To estimate the effectiveness of n...
Show More Location
Kaiser Permanente Northern California: Site number 0001
Learn More & Join Trial
Safety of RSV Preventive Monoclonal Antibody PHASE4 This is a prospective, randomized, open-label clinical trial to evaluate th...
Show More Location
Kaiser Permanente Northern California
Learn More & Join Trial
RSV Immunisation Status in Queensland (Australia) N/A The primary objective of this study is to determine the nirsevimab immunisa...
Show More Location
Paratus Clinical Research
Learn More & Join Trial